Advate

Advate

octocog alfa

Manufacturer:

Takeda

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Octocog α (recombinant human coagulation factor VIII)
Indications/Uses
Treatment & prophylaxis of bleeding in patients w/ haemophilia A (congenital factor VIII deficiency).
Dosage/Direction for Use
On-demand treatment Individualized dosage. Prophylaxis 20-40 IU/kg IV at 2-3 days interval. Childn <6 yr 20-50 IU/kg IV 3-4 times wkly.
Contraindications
Hypersensitivity to octocog α, mouse or hamster proteins.
Special Precautions
Discontinue use if hypersensitivity occurs. Monitor for development of factor VIII inhibitors. Catheter-related complications & excipient-related considerations. Pregnancy & lactation.
Adverse Reactions
Factor VIII inhibition. Headache, pyrexia.
MIMS Class
Haemostatics
ATC Classification
B02BD02 - coagulation factor VIII ; Belongs to the class of blood coagulation factors. Used in the treatment of hemorrhage.
Presentation/Packing
Form
Advate powd for inj 1,000 IU
Packing/Price
1's
Form
Advate powd for inj 1,500 IU
Packing/Price
1's
Form
Advate powd for inj 250 IU
Packing/Price
1's
Form
Advate powd for inj 500 IU
Packing/Price
1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in